Top compounds associated with response to ALS2


Feature Type Standardized
Nominal ANOVA
mRNA AS601245 GDSC1000 pan-cancer AAC -0.04 0.3
mRNA QL-VIII-58 GDSC1000 pan-cancer AAC 0.051 0.3
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.039 0.3
mRNA AZD6482 GDSC1000 pan-cancer AAC -0.036 0.3
mRNA TAE684 GDSC1000 pan-cancer AAC 0.06 0.3
mRNA Axitinib CTRPv2 pan-cancer AAC 0.038 0.3
mRNA BYL-719 CTRPv2 pan-cancer AAC -0.048 0.3
mRNA RAF265 CCLE pan-cancer AAC 0.055 0.3
mRNA temsirolimus CTRPv2 pan-cancer AAC -0.054 0.3
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.04 0.3
Download CSV